Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opiant Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Opiant Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Opiant Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is OPNT. The reporting company's CIK number is 1385508.
The total value of stock buying since 2005 is $82,450.
The total value of stock sales since 2005 is $5,568,118.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-01-17||Crystal Roger (Chief Executive Officer)||Buy||3,475||6.99||24,290|
|2017-01-17||Sinclair Michael (Executive Chairman)||Buy||3,500||7.00||24,517|
|2017-01-13||Pollack Kevin (See Remarks)||Buy||4,820||6.98||33,643|
|2015-01-15||Sinclair Michael (Executive Chairman)||Sale||1,700||3.50||5,950|
|2009-07-31||Meuse Joseph J (Director)||Sale||10,000,000||.08||780,000|
Insider trading activities including stock purchases, stock sales, and option exercises of OPNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Opiant Pharmaceuticals, Inc. (symbol OPNT, CIK number 1385508) see the Securities and Exchange Commission (SEC) website.